Article

Retrospective Analysis of the Utility of Genetic Testing in Predicting Drug Response in Chronic Pain

2021-05-04

Abstract excerpt

<h4>Introduction</h4> Chronic pain is often unrecognized and/or undertreated, and as a result has significant impact on functional abilities, quality of life, societal participation and health care utilization. Medications remain a mainstay of treatment, but selection for any given patient remains a challenge when trying to predict efficacy and/or side effects. There is interest to see whether genetic analysis of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9a5a49c8-8d2c-5e9f-88e2-7e1637292468
DOI: 10.1101/2021.04.29.21256336

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Retrospective Analysis of the Utility of Genetic Testing in Predicting Drug Response in Chronic PainDOI 10.1101/2021.04.29.21256336Read

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Semantic proximity Read

A Review of the Role of Genetic Testing in Pain MedicineSemantic proximity Read

A computational genetic- and transcriptomics-based study nominates drug repurposing candidates for the treatment of chronic painSemantic proximity Read

A systematic review of pharmacogenetic guided opioid therapy for pain.Semantic proximity Read

What is the future of pharmacogenomics in pain management?Semantic proximity Read

Pharmacogenetics and Personalized Medicine in Pain Management.Semantic proximity Read

Clinical application of pharmacogenetics in pain management.Semantic proximity Read

Genetics and Opioids: Towards More Appropriate Prescription in Cancer PainSemantic proximity Read

Genetic factors in pain and its treatment.Semantic proximity Read

Interaction of background genetic risk, psychotropic medications, and primary angle closure glaucoma in the UK BiobankSemantic proximity Read

Understanding the comorbidities among psychiatric disorders, chronic low-back pain, and spinal degenerative disease using observational and genetically informed analysesSemantic proximity Read

Evaluating the Clinical Impact of CYP2C19 and CYP2D6 on Amitriptyline Outcomes in a Real-World Chronic Pain CohortSemantic proximity Read